CytomX Therapeutics Statistics
Total Valuation
CTMX has a market cap or net worth of $985.77 million. The enterprise value is $852.96 million.
Important Dates
The next estimated earnings date is Monday, May 11, 2026, before market open.
| Earnings Date | May 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CTMX has 216.18 million shares outstanding. The number of shares has increased by 62.77% in one year.
| Current Share Class | 216.18M |
| Shares Outstanding | 216.18M |
| Shares Change (YoY) | +62.77% |
| Shares Change (QoQ) | +2.84% |
| Owned by Insiders (%) | 0.41% |
| Owned by Institutions (%) | 59.53% |
| Float | 188.20M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.94 |
| Forward PS | 43.58 |
| PB Ratio | 7.84 |
| P/TBV Ratio | 10.10 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 11.19 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.09, with a Debt / Equity ratio of 0.04.
| Current Ratio | 3.09 |
| Quick Ratio | 2.98 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -35.25% and return on invested capital (ROIC) is -21.80%.
| Return on Equity (ROE) | -35.25% |
| Return on Assets (ROA) | -8.99% |
| Return on Invested Capital (ROIC) | -21.80% |
| Return on Capital Employed (ROCE) | -18.64% |
| Weighted Average Cost of Capital (WACC) | 17.84% |
| Revenue Per Employee | $1.10M |
| Profits Per Employee | -$295,217 |
| Employee Count | 69 |
| Asset Turnover | 0.56 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CTMX has paid $238,000 in taxes.
| Income Tax | 238,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +686.21% in the last 52 weeks. The beta is 2.48, so CTMX's price volatility has been higher than the market average.
| Beta (5Y) | 2.48 |
| 52-Week Price Change | +686.21% |
| 50-Day Moving Average | 5.21 |
| 200-Day Moving Average | 3.63 |
| Relative Strength Index (RSI) | 46.66 |
| Average Volume (20 Days) | 13,628,610 |
Short Selling Information
The latest short interest is 20.42 million, so 9.44% of the outstanding shares have been sold short.
| Short Interest | 20.42M |
| Short Previous Month | 18.86M |
| Short % of Shares Out | 9.44% |
| Short % of Float | 10.85% |
| Short Ratio (days to cover) | 7.40 |
Income Statement
In the last 12 months, CTMX had revenue of $76.20 million and -$20.37 million in losses. Loss per share was -$0.15.
| Revenue | 76.20M |
| Gross Profit | 76.20M |
| Operating Income | -19.56M |
| Pretax Income | -17.13M |
| Net Income | -20.37M |
| EBITDA | -18.19M |
| EBIT | -19.56M |
| Loss Per Share | -$0.15 |
Full Income StatementBalance Sheet
The company has $137.05 million in cash and $4.24 million in debt, with a net cash position of $132.81 million or $0.61 per share.
| Cash & Cash Equivalents | 137.05M |
| Total Debt | 4.24M |
| Net Cash | 132.81M |
| Net Cash Per Share | $0.61 |
| Equity (Book Value) | 99.01M |
| Book Value Per Share | 0.58 |
| Working Capital | 97.31M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$75.59 million and capital expenditures -$220,000, giving a free cash flow of -$75.81 million.
| Operating Cash Flow | -75.59M |
| Capital Expenditures | -220,000 |
| Depreciation & Amortization | 1.38M |
| Net Borrowing | n/a |
| Free Cash Flow | -75.81M |
| FCF Per Share | -$0.35 |
Full Cash Flow StatementMargins
Gross margin is 100.00%, with operating and profit margins of -25.67% and -22.79%.
| Gross Margin | 100.00% |
| Operating Margin | -25.67% |
| Pretax Margin | -22.48% |
| Profit Margin | -22.79% |
| EBITDA Margin | -23.87% |
| EBIT Margin | -25.67% |
| FCF Margin | n/a |
Dividends & Yields
CTMX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -62.77% |
| Shareholder Yield | n/a |
| Earnings Yield | -2.07% |
| FCF Yield | -7.69% |
Analyst Forecast
The average price target for CTMX is $12.10, which is 165.35% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.10 |
| Price Target Difference | 165.35% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 25.07% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CTMX has an Altman Z-Score of -1.98 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.98 |
| Piotroski F-Score | 1 |
